HealthEquity (NASDAQ:HQY) Price Target Raised to $111.00 at Citizens Jmp

HealthEquity (NASDAQ:HQY) had its price target upped by investment analysts at Citizens Jmp from $110.00 to $111.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “market outperform” rating on the stock. Citizens Jmp’s price target points to a potential upside of 22.14% from the stock’s current price.

Other research analysts have also recently issued reports about the company. Barrington Research reiterated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their price target for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Barclays lowered their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Finally, Jefferies Financial Group set a $108.00 target price on HealthEquity in a research report on Thursday, February 19th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.53.

HealthEquity Price Performance

Shares of HQY traded up $2.89 during trading hours on Monday, reaching $90.88. The stock had a trading volume of 474,860 shares, compared to its average volume of 1,007,627. HealthEquity has a 12 month low of $72.76 and a 12 month high of $116.65. The stock has a market capitalization of $7.60 billion, a PE ratio of 34.02, a PEG ratio of 1.60 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company’s 50-day moving average is $83.44 and its two-hundred day moving average is $86.67.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity will post 3.84 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Capricorn Fund Managers Ltd bought a new position in shares of HealthEquity in the 4th quarter worth about $6,926,000. 12th Street Asset Management Company LLC raised its position in shares of HealthEquity by 114.4% in the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after acquiring an additional 145,151 shares in the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of HealthEquity by 45.5% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after acquiring an additional 48,621 shares in the last quarter. Bessemer Group Inc. raised its position in shares of HealthEquity by 21.3% in the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock worth $33,108,000 after acquiring an additional 61,317 shares in the last quarter. Finally, King Luther Capital Management Corp raised its position in shares of HealthEquity by 60.6% in the 3rd quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock worth $7,637,000 after acquiring an additional 30,394 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.